<?xml version='1.0' encoding='utf-8'?><BODY>Monoclonal Antibodies Inc
said it signed an agreement in principle to buy &lt;Genesis Labs
Inc> for about 10 mln dlrs of common stock.
    The agreement is subject to shareholders approval and other
conditions.
 Reuter
    </BODY>